NYSE:CNMD - New York Stock Exchange, Inc. - US2074101013 - Common Stock - Currency: USD
51
+1.29 (+2.6%)
The current stock price of CNMD is 51 USD. In the past month the price decreased by -15.49%. In the past year, price decreased by -22.47%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.07 | 224.39B | ||
ISRG | INTUITIVE SURGICAL INC | 66.51 | 182.05B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.46 | 149.59B | ||
SYK | STRYKER CORP | 29.62 | 137.81B | ||
MDT | MEDTRONIC PLC | 15.79 | 108.12B | ||
BDX | BECTON DICKINSON AND CO | 14.7 | 58.71B | ||
EW | EDWARDS LIFESCIENCES CORP | 28.9 | 44.17B | ||
IDXX | IDEXX LABORATORIES INC | 39.2 | 35.74B | ||
RMD | RESMED INC | 26 | 34.68B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 14.94 | 30.71B | ||
DXCM | DEXCOM INC | 42.9 | 27.75B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.65 | 23.24B |
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida and currently employs 3,900 full-time employees. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
CONMED CORP
11311 Concept Boulevard
Largo FLORIDA 33773 US
CEO: Curt R. Hartman
Employees: 4000
Company Website: https://www.conmed.com/
Investor Relations: https://www.conmed.com/en/Investor-Relations
Phone: 17272142974
The current stock price of CNMD is 51 USD. The price increased by 2.6% in the last trading session.
The exchange symbol of CONMED CORP is CNMD and it is listed on the New York Stock Exchange, Inc. exchange.
CNMD stock is listed on the New York Stock Exchange, Inc. exchange.
13 analysts have analysed CNMD and the average price target is 80.07 USD. This implies a price increase of 57% is expected in the next year compared to the current price of 51. Check the CONMED CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CONMED CORP (CNMD) has a market capitalization of 1.58B USD. This makes CNMD a Small Cap stock.
CONMED CORP (CNMD) currently has 4000 employees.
CONMED CORP (CNMD) has a resistance level at 55.21. Check the full technical report for a detailed analysis of CNMD support and resistance levels.
The Revenue of CONMED CORP (CNMD) is expected to grow by 4.29% in the next year. Check the estimates tab for more information on the CNMD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CONMED CORP (CNMD) has a dividend yield of 1.65%. The yearly dividend amount is currently 0.8. Check the full fundamental report for a detailed analysis of CNMD dividend history, reliability and sustainability.
CONMED CORP (CNMD) will report earnings on 2025-04-30, after the market close.
The PE ratio for CONMED CORP (CNMD) is 12.26. This is based on the reported non-GAAP earnings per share of 4.16 and the current share price of 51 USD. Check the full fundamental report for a full analysis of the valuation metrics for CNMD.
The outstanding short interest for CONMED CORP (CNMD) is 7.55% of its float. Check the ownership tab for more information on the CNMD short interest.
ChartMill assigns a fundamental rating of 6 / 10 to CNMD. CNMD has an excellent profitability rating, but there are some minor concerns on its financial health.
Over the last trailing twelve months CNMD reported a non-GAAP Earnings per Share(EPS) of 4.16. The EPS increased by 20.58% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 10.13% | ||
ROA | 5.74% | ||
ROE | 13.76% | ||
Debt/Equity | 0.94 |
ChartMill assigns a Buy % Consensus number of 77% to CNMD. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of 6.33% and a revenue growth 4.29% for CNMD